A retrospective study assessing the short- and long-term impact of neutropenia occurring within the first year after kidney transplantation, with a special emphasis on different neutropenia grades
Latest Information Update: 09 Nov 2021
Price :
$35 *
At a glance
- Drugs Mycophenolic acid (Primary) ; Sulfamethoxazole (Primary) ; Trimethoprim (Primary) ; Valganciclovir (Primary)
- Indications Cytomegalovirus infections; Pneumocystis pneumonia
- Focus Therapeutic Use
- 09 Nov 2021 New trial record
- 01 Oct 2021 Results published in the Transplant International